In addition, in an Australian cohort, plasma IP-10 levels were more likely to remain higher in older individuals with comorbidities (frailty, hypertension, and coronary heart disease), which correlates with other traditional cardiovascular disease surrogate plasma biomarkers, including C-reactive protein, IL-6, and fibrinogen (21). This evidence concerns the gene CXCL10 and coronary artery disorder.